CN116082374A - Boron nitride compound, composition containing boron nitride compound and application of boron nitride compound - Google Patents

Boron nitride compound, composition containing boron nitride compound and application of boron nitride compound Download PDF

Info

Publication number
CN116082374A
CN116082374A CN202111274998.0A CN202111274998A CN116082374A CN 116082374 A CN116082374 A CN 116082374A CN 202111274998 A CN202111274998 A CN 202111274998A CN 116082374 A CN116082374 A CN 116082374A
Authority
CN
China
Prior art keywords
substituted
alkyl
aryl
alkoxy
diphenylamino
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202111274998.0A
Other languages
Chinese (zh)
Inventor
王悦
李志强
宋小贤
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Jihua Hengye Foshan Electronic Materials Co ltd
Original Assignee
Jihua Hengye Foshan Electronic Materials Co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jihua Hengye Foshan Electronic Materials Co ltd filed Critical Jihua Hengye Foshan Electronic Materials Co ltd
Priority to CN202111274998.0A priority Critical patent/CN116082374A/en
Publication of CN116082374A publication Critical patent/CN116082374A/en
Pending legal-status Critical Current

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F5/00Compounds containing elements of Groups 3 or 13 of the Periodic Table
    • C07F5/02Boron compounds
    • C07F5/027Organoboranes and organoborohydrides
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K11/00Luminescent, e.g. electroluminescent, chemiluminescent materials
    • C09K11/06Luminescent, e.g. electroluminescent, chemiluminescent materials containing organic luminescent materials
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K2211/00Chemical nature of organic luminescent or tenebrescent compounds
    • C09K2211/10Non-macromolecular compounds
    • C09K2211/1018Heterocyclic compounds
    • C09K2211/1025Heterocyclic compounds characterised by ligands
    • C09K2211/1029Heterocyclic compounds characterised by ligands containing one nitrogen atom as the heteroatom
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K2211/00Chemical nature of organic luminescent or tenebrescent compounds
    • C09K2211/10Non-macromolecular compounds
    • C09K2211/1018Heterocyclic compounds
    • C09K2211/1025Heterocyclic compounds characterised by ligands
    • C09K2211/1044Heterocyclic compounds characterised by ligands containing two nitrogen atoms as heteroatoms
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K2211/00Chemical nature of organic luminescent or tenebrescent compounds
    • C09K2211/10Non-macromolecular compounds
    • C09K2211/1018Heterocyclic compounds
    • C09K2211/1025Heterocyclic compounds characterised by ligands
    • C09K2211/1044Heterocyclic compounds characterised by ligands containing two nitrogen atoms as heteroatoms
    • C09K2211/1055Heterocyclic compounds characterised by ligands containing two nitrogen atoms as heteroatoms with other heteroatoms
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K2211/00Chemical nature of organic luminescent or tenebrescent compounds
    • C09K2211/10Non-macromolecular compounds
    • C09K2211/1018Heterocyclic compounds
    • C09K2211/1025Heterocyclic compounds characterised by ligands
    • C09K2211/1059Heterocyclic compounds characterised by ligands containing three nitrogen atoms as heteroatoms
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02EREDUCTION OF GREENHOUSE GAS [GHG] EMISSIONS, RELATED TO ENERGY GENERATION, TRANSMISSION OR DISTRIBUTION
    • Y02E10/00Energy generation through renewable energy sources
    • Y02E10/50Photovoltaic [PV] energy
    • Y02E10/549Organic PV cells

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Electroluminescent Light Sources (AREA)

Abstract

The invention provides a boron nitrogen compound, a composition containing the same and application thereof. The boron-nitrogen compound is a binuclear BN compound containing carbazole skeletons, effective red shift of BN derivative spectra can be achieved by constructing a binuclear strategy, and efficient narrow spectrum TADF emission is achieved by the organic electroluminescent device prepared from the compound and the composition thereof.

Description

Boron nitride compound, composition containing boron nitride compound and application of boron nitride compound
Technical Field
The invention belongs to the technical field of organic electroluminescence, and particularly relates to a boron-nitrogen compound, a composition containing the same and application thereof.
Background
The organic photoelectric material (Organic Optoelectronic Materials) is an organic material having the characteristics of generation, conversion, transmission and the like of photons and electrons. Currently, controllable photoelectric properties of Organic photoelectric materials have been applied to Organic Light-Emitting diodes (OLEDs), organic solar cells (Organic Photovoltage, OPVs), organic field effect transistors (Organic Field Effect Transistor, OFETs), and even Organic lasers. In recent years, OLEDs have become a very popular new flat display product at home and abroad. The OLED display has the characteristics of self-luminescence, wide viewing angle, short reaction time, high luminous efficiency, wide color gamut, low working voltage, thin panel, capability of manufacturing a large-size flexible panel and low cost, and is known as a star flat display product in the 21 st century.
The history of organic electroluminescence can be traced back to the report of Bernanose et al in 1953 (see Papkovski D.B.Sens. And achuotors B.,1995,29,213.). After about 10 years, as compared with 1963, pope et al, new York university, applied a voltage across the crystals of anthracene, fluorescence emission of anthracene could be observed. (see M.Pope, H.Kallmann and P.Magnante, J.Chem.Phys.,1963,38,2042). In 1987, C.W.Tang et al, kodak, U.S. used an ultrathin film technique to prepare a light-emitting device with an aromatic amine having a good hole transport effect as a hole transport layer, an aluminum complex of 8-hydroxyquinoline as a light-emitting layer, and an Indium Tin Oxide (ITO) film and a metal alloy as an anode and a cathode, respectively. The device gave green emission at a 10V drive voltage with a luminance of up to 1000cd/m2, the efficiency of the device being 1.5lm/W (see c.w. tang and S.A.VanSlyke, appl.Phys.Lett.,1987, 51, 913). This breakthrough progress has led to rapid and intensive research into organic electroluminescence worldwide. In 1990, burroughes et al, university of Cambridge, proposed the first polymer (PPV) based light emitting diode. PPV has been shown to be highly fluorescent as an emissive material in a single layer device with high luminous efficiency (see burrouges j.h., bradley d.d. c., brown a.r., marks r.n., mackay k., friend R.H, burns p.l., holmes a.b., nature,1990,347,539.). Baldo, forrest et al, university of Princeton 1998, reported the first electroluminescent-based phosphorescent device, which in principle can have an internal quantum yield of 100%. (see M.A.Baldo, D.F.O' Briiental, nature,1998, 395, 151.) however, on the one hand, noble metals such as iridium platinum are commonly used as phosphorescent materials, and on the other hand, chemical instability still exists for deep blue phosphorescent materials, and the problem that the efficiency of the device drops greatly under high current density is solved, so that it is very important to develop an OLED device which uses cheap and stable organic small molecular materials and can realize high-efficiency luminescence.
In 2012, the Adachi research group at university of ninety reported a highly efficient fully fluorescent OLED device based on a Thermally Activated Delayed Fluorescence (TADF) mechanism. (Uoyama H, goushi K, shizu K, et al Highly efficient organic light-emitting diodes from delayed fluorescence [ J ]. Nature,2012,492 (7428):234-238.) when the S1 and T1 energy levels of the molecule differ sufficiently, triplet excitons can absorb thermal energy and return to the singlet state through the RISC process, thereby emitting fluorescence. The Internal Quantum Efficiency (IQE) of the device can reach 100% in theory, and the External Quantum Efficiency (EQE) can reach 30% or more, compared with the level of a shoulder phosphorescence device. As a next-generation light-emitting material, a TADF material is being studied.
The TADF molecules are primarily doped as guest materials in a wide bandgap host material to achieve high efficiency thermally activated delayed fluorescence (see Q.Zhang, J.Li, K.Shizu, S.Huang, S.Hirata, H.Miyazaki, C.Adachi, J.Am.Chem.Soc.2012,134,14706; H.Uoyama, K.Goushi, K.Shizu, H.Nomura, C.Adachi, nature,2012,492, 234; t. Nishimoto, t. Yasuda, s.y. Lee, r. Kondo, c. Adachi, mater. Horiz.,2014,1,264). Unlike traditional fluorescent molecular Localized (LE) state luminescence, TADF emission is mainly derived from transitions in ICT state, and is therefore susceptible to interdonor-acceptor vibration and rotational movement, resulting in a broader spectrum. The broad spectrum, while advantageous for illumination applications, does not meet the high color purity requirements of the display field. While the most important use of OLEDs is in display, narrow spectral designs (i.e., smaller full width at half maximum, FWHM) of TADF materials are necessary.
Disclosure of Invention
Aiming at the defects of the prior art, the invention aims to provide a boron nitrogen compound and application thereof. The invention aims to overcome the defect of TADF luminescent molecules, realizes effective red shift of BN derivative spectra by constructing a binuclear strategy, and relates to a binuclear boron-nitrogen compound based on carbazole skeleton as a narrow spectrum luminescent material for preparing a luminescent layer of an organic electroluminescent device, so that the prepared organic electroluminescent device realizes narrow spectrum TADF emission.
In order to achieve the aim of the invention, the invention adopts the following technical scheme:
in one aspect, the present invention provides a boron nitrogen compound having a structure represented by the following formula a:
Figure BDA0003329804340000021
wherein X is 1 、X 2 、X 3 Independently selected from N or CH;
r is independently selected from H, D (deuterium), fluorine, CN, C1-C12 alkyl, C1-C12 alkoxy, C6-C30 aryl or C5-C30 heteroaryl;
q is an integer from 0 to 4 (e.g., 0, 1, 2, 3, or 4); n is 1 or 2;
R m each occurrence is independently H, D (deuterium), fluorine, CN, C 1 ~C 20 Alkyl, C 1 ~C 20 Alkoxy, C 3 -C 10 Cycloalkyl, C 6 ~C 14 Aryl, substituted by one or more R a Substituted C 6 ~C 14 Aryl, 5-to 18-membered heteroaryl, substituted with one or more R a Substituted 5-to 18-membered heteroaryl, diphenylamino, substituted with one or more R a Substituted diphenylamino, triphenylamine, or substituted with one or more R a Substituted triphenylamine groups;
R a each occurrence is independently D (deuterium), fluorine, CN, C 1 ~C 12 Alkyl, C 1 ~C 12 Alkoxy, C 3 -C 10 Cycloalkyl, C 6 ~C 14 Aryl, substituted by one or more R b Substituted C 6 ~C 14 Aryl, 5-to 18-membered heteroaryl, substituted with one or more R b Substituted 5-to 18-membered heteroaryl, diphenylamino, substituted with one or more R b Substituted diphenylamino, triphenylamine, or substituted with one or more R b Substituted triphenylamine groups;
R b each occurrence is independently D (deuterium), fluorine, CN, C 1 ~C 12 Alkyl, C 1 ~C 12 Alkoxy, C 3 -C 10 Cycloalkyl, C 6 ~C 14 Aryl, substituted by one or more R c Substituted C 6 ~C 14 Aryl, 5-to 18-membered heteroaryl, substituted with one or more R c Substituted 5-to 18-membered heteroaryl, diphenylamino, substituted with one or more R c Substituted diphenylamino, triphenylamine, or substituted with one or more R c Substituted triphenylamine groups;
R c each occurrence is independently D (deuterium), fluorine, CN, C 1 ~C 12 Alkyl, C 1 ~C 12 Alkoxy, C 3 -C 10 Cycloalkyl, C 6 ~C 14 Aryl, substituted by one or more R d Substituted C 6 ~C 14 Aryl, 5-to 18-membered heteroaryl, substituted with one or more R d Substituted 5-to 18-membered heteroaryl, diphenylamino, substituted with one or more R d Substituted diphenylamino, triphenylamine, or substituted with one or more R d Substituted triphenylamine groups;
R d each occurrence is independently D (deuterium), fluorine, C 1 ~C 12 Alkyl, C 1 ~C 12 Alkoxy, C 3 -C 10 Cycloalkyl, C 6 ~C 14 Aryl radicals being optionally substituted by one or more R e Substituted C 6 ~C 14 An aryl group;
R e each occurrence is independently D (deuterium), fluorine, C 1 ~C 12 Alkyl, C 1 ~C 12 Alkoxy, C 3 -C 10 Cycloalkyl, or C 6 ~C 14 An aryl group;
the above alkyl, alkoxy, cycloalkyl, aryl, heteroaryl groups are optionally substituted with one or more substituents selected from the group consisting of: halogen, -CN, C 1 -C 12 Alkyl, C 1 -C 12 Alkoxy, C 1 -C 12 Haloalkyl, C 2 -C 6 Alkenyl, C 3 -C 10 Cycloalkyl, C 6 -C 14 Aryl and 5-to 18-membered heteroaryl.
In a preferred embodiment, the boron nitrogen compound is a compound having a structure represented by formula I, formula II or formula III:
Figure BDA0003329804340000031
Figure BDA0003329804340000041
X 1 、X 2 is independently N or CH, and X 1 And X 2 At least one of which is N.
X 3 Is N or CH.
R 1 、R 2 、R 3 、R 4 、R 5 And R is 6 H, D, F, CN, C independently 1 ~C 12 Alkyl, C 1 ~C 12 Alkoxy, C 6 ~C 30 Aryl or C 5 -C 30 Heteroaryl (including diphenyltriazine).
R m Each occurrence is independently H, D (deuterium), fluorine, CN, C 1 ~C 20 Alkyl, C 1 ~C 20 Alkoxy, C 3 -C 10 Cycloalkyl, C 6 ~C 14 Aryl, substituted by one or more R a Substituted C 6 ~C 14 Aryl, 5-to 18-membered heteroaryl, substituted with one or more R a Substituted 5-to 18-membered heteroaryl, diphenylamino, substituted with one or more R a Substituted diphenylamino, triphenylamine, or substituted with one or more R a Substituted triphenylamine groups;
R a each occurrence is independently D (deuterium), fluorine, CN, C 1 ~C 12 Alkyl, C 1 ~C 12 Alkoxy, C 3 -C 10 Cycloalkyl, C 6 ~C 14 Aryl, substituted by one or more R b Substituted C 6 ~C 14 Aryl, 5-to 18-membered heteroaryl, substituted with one or more R b Substituted 5-to 18-membered heteroaryl, diphenylamino, substituted with one or more R b Substituted diphenylamino, triphenylamine, or substituted with one or more R b Substituted triphenylamine groups;
R b each occurrence is independently D (deuterium), fluorine, CN, C 1 ~C 12 Alkyl, C 1 ~C 12 Alkoxy, C 3 -C 10 Cycloalkyl, C 6 ~C 14 Aryl, substituted by one or more R c Substituted C 6 ~C 14 Aryl, 5-to 18-membered heteroaryl, substituted with one or more R c Substituted 5-to 18-membered heteroaryl, diphenylamino, substituted with one or more R c Substituted diphenylamino, triphenylamine, or substituted with one or more R c Substituted triphenylamine groups;
R c each occurrence is independently D (deuterium), fluorine, CN, C 1 ~C 12 Alkyl, C 1 ~C 12 Alkoxy, C 3 -C 10 Cycloalkyl, C 6 ~C 14 Aryl, substituted by one or more R d Substituted C 6 ~C 14 Aryl, 5-to 18-membered heteroaryl, substituted with one or more R d Substituted 5-to 18-membered heteroaryl, diphenylamino, substituted with one or more R d Substituted diphenylamino, triphenylamine, or substituted with one or more R d Substituted triphenylamine groups;
R d each occurrence is independently D (deuterium), fluorine, C 1 ~C 12 Alkyl, C 1 ~C 12 Alkoxy, C 3 -C 10 Cycloalkyl, C 6 ~C 14 Aryl radicals being optionally substituted by one or more R e Substituted C 6 ~C 14 An aryl group;
R e each occurrence is independently D (deuterium), fluorine, C 1 ~C 12 Alkyl, C 1 ~C 12 Alkoxy, C 3 -C 10 Cycloalkyl, or C 6 ~C 14 An aryl group;
the above alkyl, alkoxy, cycloalkyl, aryl, heteroaryl groups are optionally substituted with one or more substituents selected from the group consisting of: halogen, -CN, C 1 -C 12 Alkyl, C 1 -C 12 Alkoxy, C 1 -C 12 Haloalkyl, C 2 -C 6 Alkenyl, C 3 -C 10 Cycloalkyl, C 6 -C 14 Aryl and 5-to 18-membered heteroaryl.
In one embodiment, the R m H, D (deuterium), fluorine, C1-C12 alkyl, C 1 ~C 12 Alkoxy, C 3 -C 10 Cycloalkyl, phenyl, substituted with at least one C 1 -C 12 Aryl substituted by alkyl, substituted by at least one C 1 -C 12 Alkoxy-substituted aryl, diphenylamino, substituted by at least one C 1 -C 12 Alkyl-substituted diphenylamino, carbazolyl, substituted by at least one C 1 -C 12 Alkyl-substituted carbazolyl.
In one embodiment, the R a Each occurrence is independently D (deuterium), fluorine, C 1 ~C 12 Alkyl, C 1 ~C 12 Alkoxy, C 3 -C 10 Cycloalkyl, at least one C 1 -C 12 Phenyl substituted by alkyl, substituted by at least one C 1 -C 12 Alkoxy-substituted phenyl, diphenylamino, substituted by at least one C 1 -C 12 Alkyl-substituted diphenylamino, carbazolyl, substituted by at least one C 1 -C 12 Alkyl-substituted carbazolyl.
In one embodiment, the R b Each occurrence is independently D (deuterium), fluorine, C 1 ~C 12 Alkyl, C 1 ~C 12 Alkoxy, C 3 -C 10 Cycloalkyl, at least one C 1 -C 12 Phenyl substituted by alkyl, substituted by at least one C 1 -C 12 Alkoxy-substituted phenyl, diphenylamino, substituted by at least one C 1 -C 12 Alkyl-substituted diphenylamino, carbazolyl, substituted by at least one C 1 -C 12 Alkyl-substituted carbazolyl.
In one embodiment, the R c Each occurrence is independently D (deuterium), fluorine, C 1 ~C 12 Alkyl, C 1 ~C 12 Alkoxy, C 3 -C 10 Cycloalkyl, at least one C 1 -C 12 Alkyl groupSubstituted phenyl, substituted with at least one C 1 -C 12 Alkoxy-substituted phenyl, diphenylamino, substituted by at least one C 1 -C 12 Alkyl-substituted diphenylamino, carbazolyl, substituted by at least one C 1 -C 12 Alkyl-substituted carbazolyl.
In one embodiment, the R d Each occurrence is independently D (deuterium), fluorine, C 1 ~C 12 Alkyl, C 1 ~C 12 Alkoxy, C 3 -C 10 Cycloalkyl, at least one C 1 -C 12 Phenyl substituted by alkyl, substituted by at least one C 1 -C 12 Alkoxy-substituted phenyl, diphenylamino, substituted by at least one C 1 -C 12 Alkyl-substituted diphenylamino, carbazolyl, substituted by at least one C 1 -C 12 Alkyl-substituted carbazolyl.
In one embodiment, the R m H, D (deuterium), fluorine, methyl, ethyl, n-propyl, isopropyl, n-butyl, tert-butyl, hexyl, octyl, decyl,
Figure BDA0003329804340000051
Methoxy, ethoxy, butoxy, hexyloxy, < >>
Figure BDA0003329804340000052
Cyclohexyl, adamantyl, phenyl, 4-methyl-phenyl, 4-ethyl-phenyl, 4-propyl-phenyl, 4-isopropylphenyl, 4-n-butylphenyl,/->
Figure BDA0003329804340000053
Figure BDA0003329804340000054
/>
Figure BDA0003329804340000061
Wherein the wavy line represents the attachment site of the group.
In some preferred embodiments, the R m Is H, methyl,
Figure BDA0003329804340000062
Phenyl group,/->
Figure BDA0003329804340000063
Figure BDA0003329804340000064
Wherein the wavy line represents the attachment site of the group.
In one embodiment, R is selected from H, F, -CN, C1-C6 alkyl substituted with at least one halogen, C1-C6 alkoxy, C6-C20 aryl substituted with at least one-CN, C6-C20 aryl substituted with a 5-to 18-membered heteroaryl, or C5-C20 heteroaryl.
In one embodiment, R is selected from H, F, CN, methyl, trifluoromethyl, methoxy, phenyl, pyridyl, biphenyl, terphenyl, cyano-substituted phenyl, diphenyltriazinyl,
Figure BDA0003329804340000065
In one embodiment R 1 、R 2 、R 3 、R 4 、R 5 And R is 6 Independently is H, F, CN, methyl, trifluoromethyl, methoxy, phenyl, pyridyl, biphenyl, terphenyl, cyano-substituted phenyl, diphenyltriazinyl,
Figure BDA0003329804340000066
Figure BDA0003329804340000067
In a preferred embodiment, the boron nitrogen compound is any one of the following compounds:
Figure BDA0003329804340000068
/>
Figure BDA0003329804340000071
/>
Figure BDA0003329804340000081
/>
Figure BDA0003329804340000091
/>
Figure BDA0003329804340000101
/>
Figure BDA0003329804340000111
/>
Figure BDA0003329804340000121
/>
Figure BDA0003329804340000131
/>
Figure BDA0003329804340000141
/>
Figure BDA0003329804340000151
/>
Figure BDA0003329804340000161
/>
Figure BDA0003329804340000171
/>
Figure BDA0003329804340000181
/>
Figure BDA0003329804340000191
/>
Figure BDA0003329804340000201
/>
Figure BDA0003329804340000211
/>
Figure BDA0003329804340000221
/>
Figure BDA0003329804340000231
/>
Figure BDA0003329804340000241
/>
Figure BDA0003329804340000251
/>
Figure BDA0003329804340000261
/>
Figure BDA0003329804340000271
/>
Figure BDA0003329804340000281
/>
Figure BDA0003329804340000291
the compounds of formulas I, II and III of the present invention can be prepared according to chemical synthesis methods conventional in the art, and the procedures and conditions can be referred to in the art as analogous procedures and conditions.
Illustratively, the basic process route for synthesizing the compounds of the present invention is as follows:
Figure BDA0003329804340000301
wherein: x is halogen;
Figure BDA0003329804340000302
in another aspect, the present invention provides an organic electroluminescent material comprising a boron nitrogen compound as described above.
In another aspect, the present invention provides an organic electroluminescent device comprising an anode and a cathode and an organic thin film layer interposed between the anode and the cathode, the organic thin film layer comprising a light emitting layer, an optional hole injection layer, an optional hole transport layer, an optional electron injection layer, wherein at least one of the light emitting layer, the electron injection layer, the electron transport layer, the hole injection layer comprises a boron nitride compound as described above.
In the invention, the boron nitride compound with the structure shown in the formula I, the formula II or the formula III can be used as a functional material in at least one layer of a light-emitting layer, an electron injection layer, an electron transport layer, a hole transport layer and a hole injection layer of an organic electroluminescent device.
In one embodiment, the organic electroluminescent device of the present invention may further comprise an optional hole blocking layer, an optional electron blocking layer, an optional capping layer, and the like.
In one embodiment, the organic electroluminescent device has a structure as shown in fig. 4, in which 1 is an ITO anode, 2 is a hole injection layer, 3 is a hole transport layer, 4 is a light emitting layer, 5 is an electron transport layer, 6 is an electron injection layer, and 7 is a metal cathode.
In one embodiment, the boron nitrogen compound with the structure shown in the formula I, the formula II or the formula III is used for preparing a light-emitting layer in an organic electroluminescent device.
In one embodiment, the organic electroluminescent device further comprises a substrate, and an anode layer, an organic light-emitting functional layer and a cathode layer sequentially formed on the substrate; the organic light-emitting functional layer comprises a light-emitting layer containing the boron-nitrogen compound, and can further comprise any one or a combination of a plurality of hole injection layer, a hole transport layer, an electron blocking layer, a hole blocking layer, an electron transport layer and an electron injection layer.
In another aspect, the present invention provides an organic electroluminescent composition comprising a boron nitride compound as described above as a doping material and a host material;
Preferably, the host material is a material having an electron transport ability and/or a hole transport ability and having a triplet excited state energy higher than or equal to that of the dopant material.
In one embodiment of the present invention, the host material in the organic electroluminescent composition is a carbazole derivative and/or carboline derivative represented by the formulas (H-1) to (H-6).
Figure BDA0003329804340000311
Wherein X is 1 、Y 1 And Z 1 Is CH or N, and X 1 、Y 1 And Z 1 At most one of which is N.
Wherein R is 1H And R is 2H Independently any of the following groups:
Figure BDA0003329804340000312
wherein X is 1 、Y 1 And Z 1 Is CH or N, and X 1 、Y 1 And Z 1 At most one of them is N;
wherein R is aH And R is bH H, C independently 1 -C 20 Alkyl, C 1 -C 20 Alkoxy, C 6 -C 20 Aryl, C 1 -C 20 Alkyl substituted C 6 -C 20 Aryl or C 1 -C 20 Alkoxy substituted C 6 -C 20 Aryl groups.
In one embodiment of the present invention, the organic electroluminescent composition preferably contains 0.3 to 30.0wt% of the boron-nitrogen compound having the structure represented by formula I or formula II as described above as a doping material, and the remaining 99.7 to 70.0wt% of the host material composed of 1 to 2 compounds of formulae (H-1) to (H-6).
In one embodiment, the host material contains 2 compounds of formulae (H-1) to (H-6) in a weight ratio of 1:5 to 5:1, such as 1:5, 1:4, 1:3, 1:2, 1:1, 2:1, 3:1, 4:1, 5:1, etc.
In one embodiment of the present invention, the host material in the organic electroluminescent composition is 1-2 of the compounds H1-1 to H1-427.
In a preferred embodiment of the present invention, the organic electroluminescent composition comprises 0.3 to 30.0wt% of any one of the compounds represented by formula I, formula II or formula III, and the remaining 99.7 to 70.0wt% of the composition is 1 to 2 of the compounds H1-1 to H1-427.
In a preferred embodiment of the present invention, the organic electroluminescent composition comprises 2 compounds of the formulae H1-1 to H1-427 as host materials in a weight ratio of 1:5 to 5:1, for example 1:5, 1:4, 1:3, 1:2, 1:1, 2:1, 3:1, 4:1, 5:1, etc.
Figure BDA0003329804340000321
/>
Figure BDA0003329804340000331
/>
Figure BDA0003329804340000341
/>
Figure BDA0003329804340000351
/>
Figure BDA0003329804340000361
/>
Figure BDA0003329804340000371
/>
Figure BDA0003329804340000381
/>
Figure BDA0003329804340000391
/>
Figure BDA0003329804340000401
/>
Figure BDA0003329804340000411
/>
Figure BDA0003329804340000421
/>
Figure BDA0003329804340000431
/>
Figure BDA0003329804340000441
/>
Figure BDA0003329804340000451
/>
Figure BDA0003329804340000461
/>
Figure BDA0003329804340000471
/>
Figure BDA0003329804340000481
/>
Figure BDA0003329804340000491
In one embodiment of the present invention, the doping material in the organic electroluminescent composition is any one of the compounds shown in formula I, formula II or formula III (the content is 0.3 wt% to 30.0 wt%); the main body material (the content is 99.7wt% -70.0wt%) is composed of any one of the compounds shown as the formula Trz1-A, trz2-A, trz3-A, trz4-A, trz5-A or Trz6-A and any one of the compounds shown as the formulas H-1 to H-6.
In a preferred embodiment, the weight ratio between the compound indicated by Trz1-A, trz2-A, trz3-A, trz4-A, trz5-A or Trz6-A and the compound indicated by H-1, H-2, H-3, H-4, H-5 or H-6 in the host material is from 1:5 to 5:1, such as 1:5, 1:4, 1:3, 1:2, 1:1, 2:1, 3:1, 4:1, 5:1, etc.
Figure BDA0003329804340000492
/>
Figure BDA0003329804340000501
Wherein R is 1a 、R 1b 、R 2a 、R 2b 、R 3a And R is 3b Wherein 1 or 2 are independently R Tz The remainder being the same or different and independently hydrogen, deuterium, C 1 -C 8 Alkyl, C 1 -C 8 Alkoxy, C 6 -C 18 Aryl, C 1 -C 8 Alkyl substituted C 6 -C 18 Aryl or C 1 -C 8 Alkoxy substituted C 6 -C 18 Aryl of (a); r is R Tz Is any one of substituent groups shown in the following formula:
Figure BDA0003329804340000502
/>
Figure BDA0003329804340000511
wherein asterisks indicate the attachment site of the group.
In one embodiment of the present invention, the doping material in the organic electroluminescent composition is any one of the compounds shown in formula I, formula II or formula III (the content is 0.3 wt% to 30.0 wt%); the main material (content of 99.7wt% -70.0wt%) is composed of any one of compounds shown as formulas TRZ-1 to TRZ-76 and any one of carbazole or carboline derivatives shown as formulas H1-1 to H1-427.
In a preferred embodiment, the weight ratio between the compound of formulae TRZ-1 to TRZ-76 and the carbazole or carboline derivative in the host material is 1:5 to 5:1, e.g. 1:5, 1:4, 1:3, 1:2, 1:1, 2:1, 3:1, 4:1, 5:1, etc.
Figure BDA0003329804340000512
/>
Figure BDA0003329804340000521
/>
Figure BDA0003329804340000531
/>
Figure BDA0003329804340000541
In another aspect, the present invention provides an organic electroluminescent material comprising an organic electroluminescent composition as described above.
In another aspect, the present invention provides an organic electroluminescent device comprising an anode and a cathode and an organic thin film layer interposed between the anode and the cathode, the organic thin film layer comprising a light emitting layer, an optional hole injection layer, an optional hole transport layer, an optional electron injection layer, wherein at least one of the light emitting layer, the electron injection layer, the electron transport layer, the hole injection layer comprises the organic electroluminescent composition as described above.
In the present invention, the organic electroluminescent composition may be used as a functional material in at least one of a light emitting layer, an electron injection layer, an electron transport layer, a hole transport layer, and a hole injection layer of an organic electroluminescent device.
In a certain embodiment of the invention, the material of the light emitting layer in the organic electroluminescent device comprises an organic electroluminescent composition as described above.
In one embodiment of the present invention, the organic electroluminescent composition is a light-emitting layer, and the light-emitting principle of the light-emitting layer is based on energy transfer from a host material to any one of the compounds represented by formula I, formula II or formula III or carrier capture of the light-emitting material itself.
In one embodiment of the invention, the organic electroluminescent composition is a light-emitting layer; the host material in the organic electroluminescent composition may be a carbazole derivative and/or a carboline derivative as shown in formulae (H-1) to (H-6). In a preferred embodiment, the organic electroluminescent composition comprises 0.3 to 30.0wt% of any one of the compounds of formula I, formula II or formula III, and the remaining 99.7 to 70.0wt% of the composition is a host composed of 1 to 2 compounds of formulae (H-1) to (H-6). For example, when the host contains 2 compounds of formulas (H-1) to (H-6), the weight ratio of the two compounds is 1:5 to 5:1.
In one embodiment of the invention, the organic electroluminescent composition is a light-emitting layer; the main materials in the composition are 1-2 of the compounds H1-1 to H1-427. In a preferred embodiment, the organic electroluminescent composition comprises 0.3-30.0wt% of any one of the compounds of formula I, formula II or formula III, and the remaining 99.7-70.0wt% of the composition is 1-2 of the compounds H1-1 to H1-427. For example, when 2 compounds of formulas H1-1 to H1-427 are included in the composition, the weight ratio of the two compounds is 1:5 to 5:1.
In one embodiment of the invention, the organic electroluminescent composition is a light-emitting layer; the doping material in the organic electroluminescent composition is any one compound shown in the formula I, the formula II or the formula III (the content is 0.3-30.0 wt%); the main body material (content of 99.7wt% -70.0wt%) is composed of any one of the compounds shown as the formula Trz1-A, trz2-A, trz3-A, trz4-A, trz5-A or Trz6-A and any one of the compounds shown as the formulas H-1 to H-6. For example, in the host material, the weight ratio of Trz1-A, trz2-A, trz3-A, trz4-A, trz5-A or Trz6-A compound to the compound of H-1, H-2, H-3, H-4, H-5 or H-6 is 1:5 to 5:1.
In one embodiment of the invention, the organic electroluminescent composition is a light-emitting layer; the doping material in the organic electroluminescent composition is any one compound shown in the formula I, the formula II or the formula III (the content is 0.3-30.0 wt%); the main material (content of 99.7wt% -70.0wt%) is composed of any one of 1,3, 5-triazine derivatives shown in formulas TRZ-1 to TRZ-76 and any one of carbazole or carboline derivatives shown in formulas H1-1 to H1-427. For example, in the host material, the weight ratio between the 1,3, 5-triazine derivative and the carbazole or carboline derivative is 1:5 to 5:1.
In one embodiment of the invention, the organic electroluminescent composition is a light-emitting layer; the doping material in the organic electroluminescent composition is any one compound (the content is 0.3-30.0 wt%) shown in the formulas BN 1-BN 396; the main body material (the content is 99.7wt% -70.0wt%) is composed of any one of the compounds shown as the formula Trz1-A, trz2-A, trz3-A, trz4-A, trz5-A and Trz6-A and any one of carbazole or carboline derivatives shown as the formulas H1-1 to H1-427. For example, in the host materials, the weight ratio between the compounds of formulae Trz1-A, trz2-A, trz3-A, trz4-A, trz5-A, and Trz6-A, and carbazole or carboline derivatives of formulae H1-1 to H1-427 is 1:5 to 5:1.
In one embodiment of the present invention, the organic electroluminescent device further comprises a substrate, and an anode layer, an organic light-emitting functional layer and a cathode layer sequentially formed on the substrate; the organic light-emitting functional layer comprises a light-emitting layer containing the organic electroluminescent composition, and can also comprise any one or more of a hole injection layer, a hole transport layer, an electron blocking layer, a hole blocking layer, an electron transport layer and an electron injection layer.
In another aspect, the invention provides an application of the organic electroluminescent device in an organic electroluminescent display or an organic electroluminescent illumination source.
Description of the terms
Unless defined otherwise, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which this invention belongs.
As used herein, the term "comprising" or "including" can be open, semi-closed, and closed. In other words, the term also includes "consisting essentially of …," or "consisting of ….
Definition of groups
In this specification, groups and substituents thereof can be selected by one skilled in the art to provide stable moieties and compounds. When substituents are described by conventional formulas written from left to right, the substituents also include chemically equivalent substituents obtained when writing formulas from right to left.
The section headings used in this specification are for organizational purposes only and are not to be construed as limiting the subject matter described. All documents or portions of documents cited in this disclosure, including but not limited to patents, patent applications, articles, books, operating manuals, and treatises, are hereby incorporated by reference in their entirety.
Unless otherwise specified, all technical and scientific terms used herein have the standard meaning of the art to which the claimed subject matter belongs. In case there are multiple definitions for a term, the definitions herein control.
As used herein, the singular forms "a", "an", and "the" are understood to include plural referents unless the context clearly dictates otherwise. Furthermore, the term "comprising" is an open-ended limitation and does not exclude other aspects, i.e. it includes the content indicated by the invention.
Unless otherwise indicated, the present invention employs conventional methods of mass spectrometry, elemental analysis, and the various steps and conditions are referred to in the art by conventional procedures and conditions.
The present invention employs, unless otherwise indicated, standard nomenclature for analytical chemistry, organic synthetic chemistry and optics, and standard laboratory procedures and techniques. In some cases, standard techniques are used for chemical synthesis, chemical analysis, and light emitting device performance detection.
The compounds of the present invention may contain non-natural proportions of atomic isotopes on one or more of the atoms comprising the compounds. For example, compounds such as deuterium (2H) may be labeled with a radioisotope. All isotopic variations of the compounds of the present invention are intended to be encompassed within the scope of the present invention.
In the present invention, the number of "substitutions" may be one or more unless otherwise specified; when plural, it means two or more, for example, may be 2, 3 or 4. In addition, when the number of "substitutions" is plural, the "substitutions" may be the same or different. In the present invention, the "substituted" position may be any position unless otherwise specified.
In the present invention, as part of a group or other groups (e.g., as used in halogen-substituted alkyl groups and the like), the term "alkyl" is meant to include both branched and straight-chain saturated aliphatic hydrocarbon groups having the indicated number of carbon atoms. For example, C 1 ~C 20 Alkyl groups include straight or branched chain alkyl groups having 1 to 20 carbon atoms. As in "C 1 ~C 6 Alkyl "is defined to include groups having 1, 2, 3, 4, 5, or 6 carbon atoms in a straight or branched chain structure. For example, in the present invention, the C1-C6 alkyl groups are each independently methyl, ethyl, propyl, butyl, pentyl or hexyl; wherein propyl is C3 alkyl (including isomers such as n-propyl or isopropyl); butyl is C4 alkyl (including isomers such as n-butyl, sec-butyl, isobutyl, or tert-butyl); pentyl is C5 alkyl (including isomers such as n-pentyl, 1-methyl-butyl, 1-ethyl-propyl, 2-methyl-1-butyl, 3-methyl-1-butyl, isopentyl, t-pentyl or neopentyl); hexyl is C6 alkyl (including isomers such as n-hexyl or isohexyl).
The term "alkoxy" as used herein refers to an alkyl group as defined above, each attached via an oxygen bond (-O-).
In the present invention, the term "Cn-m aryl" as part of a group or other group refers to a monocyclic or polycyclic aromatic group having n to m ring carbon atoms (the ring atoms being carbon atoms only) having at least one carbocyclic ring with a conjugated pi-electron system. Examples of the above aryl unit include phenyl, naphthyl, indenyl, azulenyl, fluorenyl, phenanthryl, or anthracyl. In one embodiment, the aryl group is preferably a C6-14 aryl group, such as phenyl and naphthyl, more preferably phenyl.
In the present invention, the term "n-m membered heteroaryl" as part of a group or other group means an aromatic group having one or more (e.g., 1, 2, 3 and 4) heteroatoms selected from nitrogen, oxygen and sulfur, having from n to m ring atoms, said heteroaryl being a monocyclic, bicyclic, tricyclic or tetracyclic ring system, wherein at least one ring is an aromatic ring. Heteroaryl groups within the scope of this definition include, but are not limited to: acridinyl, carbazolyl, cinnolinyl, quinoxalinyl, pyrazolyl, indolyl, benzotriazole, furanyl, thienyl, benzothienyl, benzofuranyl, quinolinyl, isoquinolinyl, oxazolyl, isoxazolyl, pyrazinyl, pyridazinyl, pyridyl, pyrimidinyl, pyrrolyl, tetrahydroquinolinyl, imidazolyl, triazolyl, tetrazolyl, thiazolyl, isothiazolyl, furazanyl, thiadiazolyl, oxadiazolyl, pyridyl, pyrazinyl, pyridazinyl, pyrimidinyl, triazinyl, purinyl, pteridinyl, naphthyridinyl, quinazolinyl, phthalazinyl, imidazopyridinyl, imidazothiazolyl, imidazooxazolyl, benzothiazolyl, benzoxazolyl, benzimidazolyl, isoindolyl, indazolyl, pyrrolopyridinyl, thienopyridinyl, benzothiadiazolyl, benzoxadiazolyl, pyrrolopyrimidinyl, thienofuranyl. In one embodiment, as preferable examples of the "5-to 18-membered heteroaryl group", furyl, thienyl, pyrrolyl, imidazolyl, thiazolyl, pyrazolyl, oxazolyl, isoxazolyl, isothiazolyl, pyridyl, pyrimidinyl and carbazolyl groups are cited, and carbazolyl groups are more preferable.
The term Cn-Cm cycloalkyl as used herein refers to mono-or multicyclic alkyls having from n to m carbon atoms, such as 3-C10 cycloalkyl and C3-C6 cycloalkyl. Examples include adamantyl, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl and bicycloheptyl. In one embodiment, the C3-C10 cycloalkyl is preferably adamantyl or cyclohexyl.
The definition of a carbon number range for a group as described in the present invention means that any integer included in the definition, such as C, of carbon atoms 1 ~C 20 Means that the number of carbon atoms of the radicals may be 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17C, 18, 19 or 20 3 -C 10 It is meant that the number of carbon atoms of the group may be 3, 4, 5, 6, 7, 8, 9 or 10, and so on for the other groups.
The above preferred conditions can be arbitrarily combined on the basis of not deviating from the common knowledge in the art, and thus, each preferred embodiment of the present invention can be obtained.
The reagents and materials used in the present invention are commercially available.
Compared with the prior art, the invention has the following beneficial effects:
the boron nitride compound adopts a binuclear strategy to realize effective red shift of a BN derivative spectrum, has a narrow spectrum, is used as a narrow spectrum luminescent material for preparing a luminescent layer of an organic electroluminescent device, realizes narrow spectrum TADF emission, and ensures that the electroluminescent external quantum efficiency of the device is up to more than 24 percent.
Drawings
FIG. 1 shows the result of the reaction of Compound BN91 in toluene (concentration: 1X 10) -5 M) photoluminescence spectrum in the sample.
FIG. 2 shows the result of the reaction of Compound BN110 in toluene (concentration: 1X 10) -5 M) photoluminescence spectrum in the sample.
FIG. 3 shows the result of the reaction of Compound BN131 in toluene (concentration: 1X 10) -5 M) photoluminescence spectrum in the sample.
Fig. 4 is a schematic view of a device structure used in effect example 2, in which 1 is an ITO anode, 2 is a hole injection layer, 3 is a hole transport layer, 4 is a light emitting layer, 5 is an electron transport layer, 6 is an electron injection layer, and 7 is a metal cathode.
Detailed Description
The technical scheme of the invention is further described by the following specific embodiments. It will be apparent to those skilled in the art that the examples are merely to aid in understanding the invention and are not to be construed as a specific limitation thereof.
In one embodiment of the invention, the compounds of formulas I, II and III are synthesized using the following starting materials in addition to the substrate 2-bromo-1, 3-difluorobenzene:
Figure BDA0003329804340000571
/>
Figure BDA0003329804340000581
/>
Figure BDA0003329804340000591
in the invention, molecular Mass spectrum data (Mass Spectra: MS) with the relative molecular weight below 1000 is measured by an ITQ1100 ion trap gas chromatograph-Mass spectrometer of Thermo Fisher company, and molecular Mass spectrum data with the relative molecular weight above 1000 is measured by an Autoflex Speed matrix auxiliary laser analysis time-of-flight Mass spectrometer of Bruker company. The elemental analysis of the final product was performed using a machine from company Elemental analysis, flash EA1112.
The fluorescence spectrum was measured by an RF-5301PC fluorescence photometer of Shimadzu corporation, japan, and the excitation wavelength selected at the time of the test was the maximum absorption wavelength.
Synthetic examples
In the first step, 35.2mmol of starting material (i.e. 3, 6-bis (4- (tert-butyl) phenyl) -9H-carbazole or its derivatives (A1 to A9), 10.24g of cesium carbonate (52.8 mmol), 3.26g of 2-bromo-1, 3-difluorobenzene (17.0 mmol) were added to a 250ml of two-necked round bottom flask, to which 80ml of anhydrous DMF solution was added the reaction system was stirred at 160℃for 24 hours, then cooled to room temperature, poured into ice water (2L) and the white solid was filtered off with suction, dried in vacuo and then further purified by column chromatography using a mixed eluent of dichloromethane/petroleum ether to give intermediate 1a as a white solid.
In the second step, 19.4mL of a solution of t-butyllithium in n-hexane (25.2 mmol) was slowly added to 100mL of a solution of t-butylbenzene containing 12.6mmol of intermediate 1a (-30 ℃ C.) under nitrogen atmosphere. Slowly heating to 60 ℃, stirring for 2 hours, cooling to-30 ℃, adding 2.4mL boron tribromide (6.3 mmol) and putting the reaction mixture inStirring was carried out at room temperature for 1 hour. 15.6mL of N, N-diisopropylethylamine (91.1 mmol) was then added at 0deg.C, and the reaction mixture was allowed to cool to room temperature after stirring for an additional 5 hours at 130deg.C. To the reaction mixture was added 5ml of methanol to quench the residual BBr 3 . The reaction system was concentrated in vacuo and purified by column chromatography with an eluent of a mixture of dichloromethane/petroleum ether to give intermediate 1b.
In a third step, intermediate 1b (6.5 mmol), 1.7g of pinacol diboronate (13 mmol) were added to tetrahydrofuran (60 mL) at room temperature, the mixture was bubbled with nitrogen for 10 minutes, and 34.9mg of 4,4 '-di-tert-butyl-2, 2' -bipyridine (0.13 mmol) and 43.1mg of methoxy (cyclooctadiene) iridium dimer (0.065 mmol) were added under high flow of nitrogen. After stirring for 10 minutes, the mixture was heated to reflux and stirred for 24 hours. After the reaction system is cooled to room temperature, the reaction system is directly concentrated under reduced pressure and purified by column chromatography to obtain an intermediate 1c.
Fourth step, intermediate 1c (6 mmol), raw material BXX (2.5 mmol), potassium carbonate (15 mmol) was added to tetrahydrofuran solution (50 ml), and 8ml of distilled water was further added, bubbled with nitrogen for 5 minutes, and 207.9mg of palladium tetraphenylphosphine (0.18 mmol) was added under high nitrogen flow, the mixture was heated to reflux and stirred for 24 hours, after the system was cooled to room temperature, concentrated under reduced pressure, and purified by column chromatography to give final product BNn, the reaction yield in this step was 28-37. The data obtained for the target compounds are shown in Table 1.
Experimental details of the synthesis examples are illustrated with regard to the compound BN 91:
In the first step, 60ml of a solution containing 15.2g of 3, 6-bis (4- (tert-butyl) phenyl) -9H-carbazole (35.2 mmol) 10.24g of cesium carbonate (52.8 mmol), 3.26g of 2-bromo-1, 3-difluorobenzene (17.0 mmol) was added to a 250ml double neck round bottom flask, to which was added 80ml of anhydrous DMF solution. The reaction was stirred at 160℃for 24 hours, then cooled to room temperature and poured into ice water (2L). The white solid was filtered off with suction, dried in vacuo and then further purified by column chromatography using a mixed eluent of dichloromethane/petroleum ether (1:3) to give 13g of intermediate 1a as a white solid. (yield 79%)
Second, 19.4mL of the mixture is subjected to tertiary reaction under the protection of nitrogen atmosphereA solution of butyllithium in n-hexane (25.2 mmol) was slowly added to a solution of 100mL of t-butylbenzene (-30 ℃ C.) containing 12.8g of intermediate 1a (12.6 mmol). After slowly heating to 60℃and stirring for 2 hours, n-hexane was removed in vacuo, then cooled to-30℃and 2.4mL of boron tribromide (6.3 mmol) was added and the reaction mixture was stirred at room temperature for 1 hour. 15.6mL of N, N-diisopropylethylamine (91.1 mmol) was then added at 0deg.C, and the reaction mixture was allowed to cool to room temperature after stirring for an additional 5 hours at 130deg.C. To the reaction mixture was added 5ml of methanol to quench the residual BBr 3 . The reaction was concentrated in vacuo and purified by column chromatography with a dichloromethane/petroleum ether (1:2) mixture eluent to give 4.2 g of intermediate 1b as a bright green solid (34% yield).
In a third step, 4.1g of intermediate 1b (6.5 mmol), 1.7g of pinacol diboronate (13 mmol) were added to tetrahydrofuran (60 mL), the mixture was bubbled with nitrogen for 10 minutes and 34.9mg of 4,4 '-di-tert-butyl-2, 2' -bipyridine (0.13 mmol) and 43.1mg of methoxy (cyclooctadiene) iridium dimer (0.065 mmol) were added under high flow of nitrogen. After stirring for 10 minutes, the mixture was heated to reflux and stirred for 24 hours. After the reaction system was cooled to room temperature, it was concentrated under reduced pressure, and purified by column chromatography to give 4.17g of intermediate 1c (yield 85%).
Fourth, 4.5g of intermediate 1c (6 mmol), 2.0g of potassium carbonate (15 mmol), 0.76g of B3 (2.5 mmol) were added to tetrahydrofuran (50 ml), 8ml of distilled water was further added, bubbling was performed for 5 minutes with nitrogen, and 207.9mg of tetra-triphenylphosphine palladium (0.18 mmol) was added under a high nitrogen flow, and the mixture was heated to reflux and stirred for 36 hours, and after the system was cooled to room temperature, concentrated under reduced pressure, and purified by column chromatography to give 1.2g of final product BN. (yield 33%)
TABLE 1
Figure BDA0003329804340000601
/>
Figure BDA0003329804340000611
/>
Figure BDA0003329804340000621
/>
Figure BDA0003329804340000631
/>
Figure BDA0003329804340000641
/>
Figure BDA0003329804340000651
/>
Figure BDA0003329804340000661
/>
Figure BDA0003329804340000671
/>
Figure BDA0003329804340000681
FIG. 1 shows the presence of Compound BN91 in toluene (concentration: 1X 10) -5 M), fig. 2 is a fluorescence spectrum of the compound BN110 in toluene solution (concentration: 1X 10 -5 M), fig. 3 is a fluorescence spectrum of compound BN131 in toluene solution (concentration: 1X 10 -5 M), it can be seen from fig. 1-3 that the luminescence of such compounds has a very narrow half-width.
Electroluminescent device embodiment
Some representative electroluminescent device embodiments are given below, and some of the material molecular structures involved in the device embodiments are as follows:
Figure BDA0003329804340000682
the following embodiment of electroluminescent devices prepared by using the material of the present invention, the specific device preparation process is as follows:
(1) And (3) substrate processing: the transparent ITO glass is used as a substrate material for preparing devices, is subjected to ultrasonic treatment for 30min by using 5% ITO washing liquid, is sequentially subjected to ultrasonic washing by using distilled water (2 times), acetone (2 times) and isopropanol (2 times), and is finally stored in isopropanol. Before each use, the surface of the ITO glass is carefully wiped by acetone cotton balls and isopropanol cotton balls, and after the isopropanol is washed, the ITO glass is dried, and then is treated by plasma for 5min for standby. The preparation of the device is completed by combining spin coating and vacuum evaporation process.
(2) Hole injection lamination hole transport layer preparation: a layer of 20nm thick PEDOT PSS (Poly 3, 4-ethylenedioxythiophene) polystyrene sulfonate, which is commercially available from Heraeus Corp. Germany, was first spin-coated on the ITO surface as a hole injection layer, then a 50nm thick Poly-HTL was spin-coated on the hole injection layer as a hole transport layer, and then the ITO glass with the hole injection layer and the hole transport layer was annealed at 200℃for 30 minutes in a nitrogen-protected glove box (cross-linking the Poly-HTL).
(3) Preparing a light-emitting layer: the main material and the luminescent material are dissolved in dimethylbenzene according to the proportion of 97wt% (weight percent concentration) to prepare a solution with the concentration of 2wt%, and the prepared solution is used for preparing the luminescent layer by spin coating, wherein the thickness of the luminescent layer is 50nm.
(4) Preparation of an electron transport layer, an electron injection layer and a metal electrode: an electron transport layer, an electron injection layer and a metal electrode are prepared by adopting an evaporation process, and when the vacuum degree of a vacuum evaporation system reaches 5 multiplied by 10 -4 And starting evaporation when Pa is lower, wherein the deposition rate is equal to or lower than that of the Sien film thickness meter, and sequentially depositing an organic electronic transmission layer, a LiF electron injection layer and a metal Al electrode on the light-emitting layer by utilizing a vacuum evaporation process (the specific device structure is shown in the following effect example). Wherein the deposition rate of the organic material is
Figure BDA0003329804340000694
Deposition rate of LiF->
Figure BDA0003329804340000692
The deposition rate of Al is->
Figure BDA0003329804340000693
Device examples A1 to A135
In the organic electroluminescent device (structure shown in FIG. 4) in device examples A1-A135, PEDOT: PSS was used as a hole injection layer, poly-HTL was used as a hole transport layer, H1-48 was used as a host material in a light emitting layer, BNn was used as a doped light emitting material (doping concentration was 2 wt%), TRZ-8 was used as an electron transport material, liF was used as an electron injection layer, and Al was used as a metal cathode, respectively. Effect example the organic electroluminescent device structure was [ ITO/PEDOT: PSS (20 nm)/Poly-HTL (50 nm)// H1-33+3wt% bnn/TRZ-8 (50 nm)/LiF (1 nm)/Al (100 nm) ].
The current, voltage, brightness, luminescence spectrum and other characteristics of the device were synchronously tested using a Photo Research PR 655 spectral scanning luminance meter and a Keithley K2400 digital source meter system. The performance test of the device was performed at room temperature under ambient atmosphere. The External Quantum Efficiency (EQE) of the device is calculated from the current density, brightness and electro-spectral combined with the visual function in the case of the light emission as a langerhans distribution.
The test results are shown in Table 2.
TABLE 2
Figure BDA0003329804340000691
/>
Figure BDA0003329804340000701
/>
Figure BDA0003329804340000711
/>
Figure BDA0003329804340000721
The electroluminescent device effect implementation data listed in table 2 prove that the luminescent material provided by the present disclosure can be used for preparing high-efficiency organic electroluminescent devices, and the electroluminescent spectrum has narrow band characteristics, the half-peak width of the electroluminescent spectrum is less than 60nm, and the electroluminescent external quantum efficiency is as high as more than 24.6%.
Device examples B1 to B135
In the organic electroluminescent device in device examples B1 to B135, in the organic electroluminescent device (structure shown in FIG. 4) in effect example 2, PEDOT: PSS was used as a hole injection layer, poly-HTL was used as a hole transport layer, a mixture of H1-33 and TRZ-8 in a light emitting layer was used as a host material (weight mixing ratio of H1-33 to TRZ-1 was 1:1), BN-1 to BN-100 were used as doped light emitting materials (doping concentration was 3 wt%), TRZ-8 was used as an electron transport material, liF was used as an electron injection layer, and Al was used as a metal cathode, respectively. Effect example the organic electroluminescent device structure was [ ITO/PEDOT: PSS (20 nm)/Poly-HTL (50 nm)/H1-33:trz-8+3wt% bnn/TRZ-8 (50 nm)/LiF (1 nm)/Al (100 nm) ].
The effect of the device was also tested, the peak position and half-width of the electroluminescent spectrum, and the electroluminescent external quantum efficiency were tested, and the test results are shown in table 3.
TABLE 3 Table 3
Figure BDA0003329804340000731
/>
Figure BDA0003329804340000741
/>
Figure BDA0003329804340000751
/>
Figure BDA0003329804340000761
The electroluminescent device implementation data listed in table 3 prove that the luminescent material provided by the invention can be used for preparing high-efficiency organic electroluminescent devices, and the electroluminescent spectrum has narrow band characteristics, the half-peak width of the electroluminescent spectrum is less than 60nm, and the electroluminescent external quantum efficiency is as high as more than 26.4%.
The applicant states that the present invention is illustrated by the above examples of compositions comprising the boron nitride compounds of the present invention and their use, but the present invention is not limited to, i.e. does not mean that the present invention must be practiced in dependence upon, the above examples. It should be apparent to those skilled in the art that any modification of the present invention, equivalent substitution of selected raw materials, addition of auxiliary components, selection of specific modes, etc. fall within the scope of the present invention and the scope of disclosure.

Claims (10)

1. A boron nitride compound, characterized in that the boron nitride compound is a compound having a structure represented by the following formula a:
Figure FDA0003329804330000011
wherein X is 1 、X 2 、X 3 Independently selected from N or CH;
R is independently selected from H, deuterium, fluorine, CN, C1-C12 alkyl, C1-C12 alkoxy, C6-C30 aryl or C5-C30 heteroaryl;
q is an integer from 0 to 4; n is 1 or 2;
R m each occurrence is independently H, deuterium, fluorine, CN, C 1 ~C 20 Alkyl, C 1 ~C 20 Alkoxy, C 3 -C 10 Cycloalkyl, C 6 ~C 14 Aryl, substituted by one or more R a Substituted C 6 ~C 14 Aryl, 5-to 18-membered heteroaryl, substituted with one or more R a Substituted 5-to 18-membered heteroaryl, diphenylamino, substituted with one or more R a Substituted diphenylamino, triphenylamine, or substituted with one or more R a Substituted triphenylamine groups;
R a each occurrence is independently deuterium, fluorine, CN, C 1 ~C 12 Alkyl, C 1 ~C 12 Alkoxy, C 3 -C 10 Cycloalkyl, C 6 ~C 14 Aryl, substituted by one or more R b Substituted C 6 ~C 14 Aryl, 5-to 18-membered heteroaryl, substituted with one or more R b Substituted 5-to 18-membered heteroaryl, diphenylamino, substituted with one or more R b Substituted diphenylamino, triphenylamine, or substituted with one or more R b Substituted triphenylamine groups;
R b each occurrence is independently deuterium, fluorine, CN, C 1 ~C 12 Alkyl, C 1 ~C 12 Alkoxy, C 3 -C 10 Cycloalkyl, C 6 ~C 14 Aryl, substituted by one or more R c Substituted C 6 ~C 14 Aryl, 5-to 18-membered heteroaryl, substituted with one or more R c Substituted 5-to 18-membered heteroaryl, diphenylamino, substituted with one or more R c Substituted diphenylamino, triphenylamine, or substituted with one or more R c Substituted triphenylamine groups;
R c each occurrence is independently deuterium, fluorine, CN, C 1 ~C 12 Alkyl, C 1 ~C 12 Alkoxy, C 3 -C 10 Cycloalkyl, C 6 ~C 14 Aryl, substituted by one or more R d Substituted C 6 ~C 14 Aryl, 5-to 18-membered heteroaryl, substituted with one or more R d Substituted 5-to 18-membered heteroaryl, diphenylamino, substituted with one or more R d Substituted diphenylamino, triphenylamine, or substituted with one or more R d Substituted triphenylamine groups;
R d each occurrence is independently deuterium, fluorine, C 1 ~C 12 Alkyl, C 1 ~C 12 Alkoxy, C 3 -C 10 Cycloalkyl, C 6 ~C 14 Aryl radicals being optionally substituted by one or more R e Substituted C 6 ~C 14 An aryl group;
R e each occurrence is independently deuterium, fluorine, C 1 ~C 12 Alkyl, C 1 ~C 12 Alkoxy, C 3 -C 10 Cycloalkyl, or C 6 ~C 14 An aryl group;
the alkyl, alkoxy, cycloalkyl, aryl, heteroaryl groups are optionally substituted with one or more substituents selected from the group consisting of: halogen, -CN, C 1 -C 12 Alkyl, C 1 -C 12 Alkoxy, C 1 -C 12 Haloalkyl, C 2 -C 6 Alkenyl, C 3 -C 10 Cycloalkyl, C 6 -C 14 Aryl and 5-to 18-membered heteroaryl.
2. The boron nitride compound according to claim 1, wherein the boron nitride compound is a compound having a structure represented by the following formula I, formula II or formula III:
Figure FDA0003329804330000021
/>
X 1 、X 2 Is independently N or CH, and X 1 And X 2 At least one of which is N;
X 3 is N or CH;
R 1 、R 2 、R 3 、R 4 、R 5 and R is 6 H, D, F, CN, C independently 1 ~C 12 Alkyl, C 1 ~C 12 Alkoxy, C 6 ~C 30 Aryl or C 5 -C 30 Heteroaryl;
R m each occurrence is independently H, deuterium, fluorine, CN, C 1 ~C 20 Alkyl, C 1 ~C 20 Alkoxy, C 3 -C 10 Cycloalkyl, C 6 ~C 14 Aryl, by one or moreMultiple R' s a Substituted C 6 ~C 14 Aryl, 5-to 18-membered heteroaryl, substituted with one or more R a Substituted 5-to 18-membered heteroaryl, diphenylamino, substituted with one or more R a Substituted diphenylamino, triphenylamine, or substituted with one or more R a Substituted triphenylamine groups;
R a each occurrence is independently deuterium, fluorine, CN, C 1 ~C 12 Alkyl, C 1 ~C 12 Alkoxy, C 3 -C 10 Cycloalkyl, C 6 ~C 14 Aryl, substituted by one or more R b Substituted C 6 ~C 14 Aryl, 5-to 18-membered heteroaryl, substituted with one or more R b Substituted 5-to 18-membered heteroaryl, diphenylamino, substituted with one or more R b Substituted diphenylamino, triphenylamine, or substituted with one or more R b Substituted triphenylamine groups;
R b each occurrence is independently deuterium, fluorine, CN, C 1 ~C 12 Alkyl, C 1 ~C 12 Alkoxy, C 3 -C 10 Cycloalkyl, C 6 ~C 14 Aryl, substituted by one or more R c Substituted C 6 ~C 14 Aryl, 5-to 18-membered heteroaryl, substituted with one or more R c Substituted 5-to 18-membered heteroaryl, diphenylamino, substituted with one or more R c Substituted diphenylamino, triphenylamine, or substituted with one or more R c Substituted triphenylamine groups;
R c each occurrence is independently deuterium, fluorine, CN, C 1 ~C 12 Alkyl, C 1 ~C 12 Alkoxy, C 3 -C 10 Cycloalkyl, C 6 ~C 14 Aryl, substituted by one or more R d Substituted C 6 ~C 14 Aryl, 5-to 18-membered heteroaryl, substituted with one or more R d Substituted 5-to 18-membered heteroaryl, diphenylamino, substituted with one or more R d Substituted diphenylamino, triphenylamine, or substituted with one or more R d Substituted triphenylamine groups;
R d at each occurrence independentlyThe standing site is deuterium, fluorine and C 1 ~C 12 Alkyl, C 1 ~C 12 Alkoxy, C 3 -C 10 Cycloalkyl, C 6 ~C 14 Aryl radicals being optionally substituted by one or more R e Substituted C 6 ~C 14 An aryl group;
R e independently for each occurrence; deuterium, fluorine, C 1 ~C 12 Alkyl, C 1 ~C 12 Alkoxy, C 3 -C 10 Cycloalkyl, or C 6 ~C 14 An aryl group;
the above alkyl, alkoxy, cycloalkyl, aryl, heteroaryl groups are optionally substituted with one or more substituents selected from the group consisting of: halogen, -CN, C 1 -C 12 Alkyl, C 1 -C 12 Alkoxy, C 1 -C 12 Haloalkyl, C 2 -C 6 Alkenyl, C 3 -C 10 Cycloalkyl, C 6 -C 14 Aryl and 5-to 18-membered heteroaryl.
3. The boron nitride compound according to claim 1 or 2, wherein R m Is H, deuterium, fluorine, C1-C12 alkyl, C 1 ~C 12 Alkoxy, C 3 -C 10 Cycloalkyl, phenyl, substituted with at least one C 1 -C 12 Aryl substituted by alkyl, substituted by at least one C 1 -C 12 Alkoxy-substituted aryl, diphenylamino, substituted by at least one C 1 -C 12 Alkyl-substituted diphenylamino, carbazolyl, substituted by at least one C 1 -C 12 Alkyl-substituted carbazolyl;
preferably, said R a Each occurrence is independently deuterium, fluorine, C 1 ~C 12 Alkyl, C 1 ~C 12 Alkoxy, C 3 -C 10 Cycloalkyl, at least one C 1 -C 12 Phenyl substituted by alkyl, substituted by at least one C 1 -C 12 Alkoxy-substituted phenyl, diphenylamino, substituted by at least one C 1 -C 12 Alkyl-substituted diphenylamino, carbazolyl, substituted by at least one C 1 -C 12 Alkyl-substituted carbazolyl;
preferably, said R b Each occurrence is independently deuterium, fluorine, C 1 ~C 12 Alkyl, C 1 ~C 12 Alkoxy, C 3 -C 10 Cycloalkyl, at least one C 1 -C 12 Phenyl substituted by alkyl, substituted by at least one C 1 -C 12 Alkoxy-substituted phenyl, diphenylamino, substituted by at least one C 1 -C 12 Alkyl-substituted diphenylamino, carbazolyl, substituted by at least one C 1 -C 12 Alkyl-substituted carbazolyl;
preferably, said R c Each occurrence is independently deuterium, fluorine, C 1 ~C 12 Alkyl, C 1 ~C 12 Alkoxy, C 3 -C 10 Cycloalkyl, at least one C 1 -C 12 Phenyl substituted by alkyl, substituted by at least one C 1 -C 12 Alkoxy-substituted phenyl, diphenylamino, substituted by at least one C 1 -C 12 Alkyl-substituted diphenylamino, carbazolyl, substituted by at least one C 1 -C 12 Alkyl-substituted carbazolyl;
preferably, said R d Each occurrence is independently deuterium, fluorine, C 1 ~C 12 Alkyl, C 1 ~C 12 Alkoxy, C 3 -C 10 Cycloalkyl, at least one C 1 -C 12 Phenyl substituted by alkyl, substituted by at least one C 1 -C 12 Alkoxy-substituted phenyl, diphenylamino, substituted by at least one C 1 -C 12 Alkyl-substituted diphenylamino, carbazolyl, substituted by at least one C 1 -C 12 Alkyl-substituted carbazolyl;
preferably, said R m H, deuterium, fluorine, methyl, ethyl, n-propyl, isopropyl, n-butyl, tert-butyl, hexyl, octyl, decyl,
Figure FDA0003329804330000031
Methoxy, ethoxy, butoxy, hexyloxy, < >>
Figure FDA0003329804330000032
Cyclohexyl, adamantyl, phenyl, 4-methyl-phenyl, 4-ethyl-phenyl, 4-propyl-phenyl, 4-isopropylphenyl, 4-n-butylphenyl,
Figure FDA0003329804330000041
Figure FDA0003329804330000042
Wherein the wavy line represents the attachment site of the group; />
Preferably, said R m Is H, methyl,
Figure FDA0003329804330000043
Phenyl group,/->
Figure FDA0003329804330000044
Figure FDA0003329804330000051
Wherein the wavy line represents the attachment site of the group;
preferably, R is selected from H, F, -CN, C1-C6 alkyl substituted with at least one halogen, C1-C6 alkoxy, C6-C20 aryl substituted with at least one-CN, C6-C20 aryl substituted with 5-to 18-membered heteroaryl, or C5-C20 heteroaryl;
Preferably, R is selected from H, F, CN, methyl, trifluoromethyl, methoxy, phenyl, pyridyl, biphenyl, terphenyl, cyano-substituted phenyl, diphenyltriazinyl,
Figure FDA0003329804330000052
Preferably, R 1 、R 2 、R 3 And R is 4 Is independently H, F, CN, methyl, trifluoromethyl, methoxy, phenylPyridyl, biphenyl, terphenyl, cyano-substituted phenyl, diphenyltriazinyl,
Figure FDA0003329804330000053
Preferably, R 5 And R is 6 Independently H, F, CN, methyl, trifluoromethyl, methoxy, phenyl, pyridyl, biphenyl, terphenyl, cyano-substituted phenyl, diphenyltriazinyl,
Figure FDA0003329804330000054
4. A boron nitride compound according to any one of claims 1 to 3, wherein the boron nitride compound is any one of the following compounds:
Figure FDA0003329804330000055
/>
Figure FDA0003329804330000061
/>
Figure FDA0003329804330000071
/>
Figure FDA0003329804330000081
/>
Figure FDA0003329804330000091
/>
Figure FDA0003329804330000101
/>
Figure FDA0003329804330000111
/>
Figure FDA0003329804330000121
/>
Figure FDA0003329804330000131
/>
Figure FDA0003329804330000141
/>
Figure FDA0003329804330000151
/>
Figure FDA0003329804330000161
/>
Figure FDA0003329804330000171
/>
Figure FDA0003329804330000181
/>
Figure FDA0003329804330000191
/>
Figure FDA0003329804330000201
/>
Figure FDA0003329804330000211
/>
Figure FDA0003329804330000221
/>
Figure FDA0003329804330000231
/>
Figure FDA0003329804330000241
/>
Figure FDA0003329804330000251
/>
Figure FDA0003329804330000261
/>
Figure FDA0003329804330000271
/>
Figure FDA0003329804330000281
5. an organic electroluminescent composition, characterized in that it comprises the boron nitride compound according to any one of claims 1 to 4 and a host material as doping materials;
preferably, the host material is a material having an electron transport ability and/or a hole transport ability and having a triplet excited state energy higher than or equal to that of the dopant material;
preferably, the host material in the organic electroluminescent composition is a carbazole derivative and/or carboline derivative represented by formulae (H-1) to (H-6):
Figure FDA0003329804330000282
/>
Figure FDA0003329804330000291
Wherein X is 1 、Y 1 And Z 1 Is CH or N, and X 1 、Y 1 And Z 1 At most one of them is N;
wherein R is 1H And R is 2H Independently any of the following groups:
Figure FDA0003329804330000292
wherein X is 1 、Y 1 And Z 1 Is CH or N, and X 1 、Y 1 And Z 1 At most one of them is N;
wherein R is aH And R is bH H, C independently 1 -C 20 Alkyl, C 1 -C 20 Alkoxy, C 6 -C 20 Aryl, C 1 -C 20 Alkyl substituted C 6 -C 20 Aryl or C 1 -C 20 Alkoxy substituted C 6 -C 20 An aryl group;
preferably, the organic electroluminescent composition preferably contains 0.3 to 30.0wt% of the boron-nitrogen compound as defined in any one of claims 1 to 4 as a doping material, and the remaining 99.7 to 70.0wt% of the host material composed of 1 to 2 compounds of formulae (H-1) to (H-6).
Preferably, the host material contains 2 compounds of formulae (H-1) to (H-6) in a weight ratio of 1:5 to 5:1;
preferably, the host material in the organic electroluminescent composition is 1-2 of the compounds H1-1 to H1-427;
Figure FDA0003329804330000293
/>
Figure FDA0003329804330000301
/>
Figure FDA0003329804330000311
/>
Figure FDA0003329804330000321
/>
Figure FDA0003329804330000331
/>
Figure FDA0003329804330000341
/>
Figure FDA0003329804330000351
/>
Figure FDA0003329804330000361
/>
Figure FDA0003329804330000371
/>
Figure FDA0003329804330000381
/>
Figure FDA0003329804330000391
/>
Figure FDA0003329804330000401
/>
Figure FDA0003329804330000411
/>
Figure FDA0003329804330000421
/>
Figure FDA0003329804330000431
/>
Figure FDA0003329804330000441
/>
Figure FDA0003329804330000451
/>
Figure FDA0003329804330000461
/>
Figure FDA0003329804330000471
preferably, the organic electroluminescent composition comprises 0.3-30.0wt% of the boron-nitrogen compound according to any one of claims 1-4, and the remaining 99.7-70.0wt% of the boron-nitrogen compound is 1-2 compounds from compounds H1-1 to H1-427.
Preferably, the organic electroluminescent composition contains 2 compounds in the formulas H1-1 to H1-427 as a main material, wherein the weight ratio of the two compounds is 1:5 to 5:1;
6. The organic electroluminescent composition according to claim 5, wherein the doping material in the organic electroluminescent composition is any one of boron-nitrogen compounds having a structure represented by formula I or formula II; the main material is composed of any one of compounds shown as the formula Trz1-A, trz2-A, trz3-A, trz4-A, trz5-A or Trz6-A and any one of compounds shown as the formulas H-1 to H-6;
Figure FDA0003329804330000472
wherein R is 1a 、R 1b 、R 2a 、R 2b 、R 3a And R is 3b Wherein 1 or 2 are independently R Tz The remainder being the same or different and independently hydrogen, deuterium, C 1 -C 8 Alkyl, C 1 -C 8 Alkoxy, C 6 -C 18 Aryl, C 1 -C 8 Alkyl substituted C 6 -C 18 Aryl or C 1 -C 8 Alkoxy substituted C 6 -C 18 Aryl of (a); r is R Tz Is any one of substituent groups shown in the following formula:
Figure FDA0003329804330000473
/>
Figure FDA0003329804330000481
/>
Figure FDA0003329804330000491
wherein asterisks represent the attachment site of the group;
preferably, the weight ratio of the Trz1-A, trz2-A, trz3-A, trz4-A, trz5-A or Trz6-A compound to the H-1, H-2, H-3, H-4, H-5 or H-6 compound in the main material is 1:5-5:1;
7. the organic electroluminescent composition as claimed in claim 5 or 6, wherein the doping material in the organic electroluminescent composition is any one of the boron-nitrogen compounds as claimed in any one of claims 1 to 4; the main material is composed of any one of compounds shown as formulas TRZ-1 to TRZ-76 and any one of carbazole or carboline derivatives shown as formulas H1-1 to H1-427;
Figure FDA0003329804330000492
/>
Figure FDA0003329804330000501
/>
Figure FDA0003329804330000511
/>
Figure FDA0003329804330000521
Preferably, the weight ratio between the compound represented by the formulas TRZ-1 to TRZ-76 and the carbazole or carboline derivative in the host material is 1:5 to 5:1.
8. An organic electroluminescent material, characterized in that it comprises a boron nitrogen compound according to any one of claims 1 to 4 or an organic electroluminescent composition according to any one of claims 5 to 7.
9. An organic electroluminescent device comprising an anode and a cathode and an organic thin film layer disposed between the anode and the cathode, the organic thin film layer comprising a light emitting layer, an optional hole injection layer, an optional hole transport layer, an optional electron injection layer, wherein at least one of the light emitting layer, the electron injection layer, the electron transport layer, the hole injection layer comprises the boron-nitrogen compound of any one of claims 1-4 or the organic electroluminescent composition of any one of claims 5-7;
preferably, the light-emitting layer comprises the boron nitrogen compound according to any one of claims 1 to 4 or the organic electroluminescent composition according to any one of claims 5 to 7;
Preferably, the organic electroluminescent device further comprises an optional hole blocking layer, an optional electron blocking layer and an optional capping layer.
10. Use of an organic electroluminescent device according to claim 9 in an organic electroluminescent display or an organic electroluminescent illumination source.
CN202111274998.0A 2021-10-29 2021-10-29 Boron nitride compound, composition containing boron nitride compound and application of boron nitride compound Pending CN116082374A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202111274998.0A CN116082374A (en) 2021-10-29 2021-10-29 Boron nitride compound, composition containing boron nitride compound and application of boron nitride compound

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202111274998.0A CN116082374A (en) 2021-10-29 2021-10-29 Boron nitride compound, composition containing boron nitride compound and application of boron nitride compound

Publications (1)

Publication Number Publication Date
CN116082374A true CN116082374A (en) 2023-05-09

Family

ID=86210636

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202111274998.0A Pending CN116082374A (en) 2021-10-29 2021-10-29 Boron nitride compound, composition containing boron nitride compound and application of boron nitride compound

Country Status (1)

Country Link
CN (1) CN116082374A (en)

Similar Documents

Publication Publication Date Title
CN112645968B (en) Fused ring compound containing two boron atoms and two oxygen family atoms and organic electroluminescent device
CN110627822A (en) Green light narrow spectrum three-coordination boron luminescent compound, luminescent composition and application thereof
CN106221691B (en) Organic electroluminescent device containing aza-phenyl compounds and application thereof
Kim et al. Orange phosphorescent organic light-emitting diodes using new spiro [benzoanthracene-fluorene]-type host materials
CN113666951A (en) Boron-nitrogen compound, organic electroluminescent composition and organic electroluminescent device comprising same
CN113004292A (en) Main luminescent material based on triazolotriazine and application thereof
CN116514859A (en) Narrow-emission luminescent compound and application thereof in electronic device
CN114249759A (en) Bora Z-type acene derivative and preparation method and application thereof
CN116023402B (en) Boron-nitrogen compound and preparation method and application thereof
CN110183361B (en) Construction and application of cross-shaped thermal activity delay fluorescent material
CN114478588B (en) Organic compound based on pyrene and indolocarbazole, organic electroluminescent composition and organic electroluminescent device
CN116120349A (en) Boron-nitrogen compound and preparation method and application thereof
CN116120350A (en) Boron-nitrogen compound and preparation method and application thereof
CN116836193A (en) Organic compound, application thereof and organic electroluminescent device comprising same
CN116156980A (en) Organic electroluminescent device and application thereof
CN113861206B (en) Blue electroluminescent material and synthesis method and application thereof
CN114621272B (en) Boron nitride compound, organic electroluminescent composition and organic electroluminescent device comprising same
CN114621274B (en) Boron nitride compound, organic electroluminescent composition and organic electroluminescent device comprising same
CN116082374A (en) Boron nitride compound, composition containing boron nitride compound and application of boron nitride compound
CN116082375A (en) Boron nitride compound and application thereof
CN116082373A (en) Boron nitride compound, composition containing boron nitride compound and application of boron nitride compound
CN116082372A (en) Boron-nitrogen compound and preparation method and application thereof
CN114621271A (en) Boron-nitrogen compound, organic electroluminescent composition and organic electroluminescent device comprising same
CN116925113A (en) Boron nitrogen heterocyclic compound, composition containing same and application thereof
CN116120351A (en) Boron-nitrogen compound and preparation method and application thereof

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination